-
Je něco špatně v tomto záznamu ?
An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole
K. Rudolf, E. Rudolf
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
- MeSH
- apoptóza účinky léků MeSH
- autofagie účinky léků MeSH
- buněčný cyklus účinky léků MeSH
- cytochromy c metabolismus MeSH
- JNK mitogenem aktivované proteinkinasy metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- mebendazol analogy a deriváty farmakologie MeSH
- melanom farmakoterapie metabolismus MeSH
- membránový potenciál mitochondrií účinky léků MeSH
- mitóza MeSH
- nádorové buněčné linie MeSH
- nádorový supresorový protein p53 metabolismus MeSH
- protein MCL-1 metabolismus MeSH
- protinádorové látky farmakologie MeSH
- protoonkogenní proteiny c-bcl-2 metabolismus MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
Mitotic catastrophe induced by mictotubule-targeting drugs such as benzimidazole carbamates has been demonstrated to be an efficient mechanism for suppression of tumor cells growth and proliferation, with variable resulting endpoints. The present study was designed to explore some of these endpoints; i.e. the apoptosis as well as autophagy and their related signaling in several stabilized cell lines as well as human explant melanoma cells treated with flubendazole (FLU). FLU-induced mitotic catastrophe resulted in mitochondrial and caspase-dependent apoptosis, which occurred at various rates in all treated cells during 96 h of treatment. The process was characterized by enhanced transcriptional activity of TP53 and NF-κB as well as upregulated Noxa expression. Also, inactivation of Bcl-2, BclXL and Mcl-1 proteins by JNK mediated phosphorylation was observed. Although increased autophagic activity took place in treated cells too, no discernible functional linkage with ongoing cell death process was evidenced. Together these results advance our evidence over the effectiveness of FLU cytotoxicity-related killing of melanoma cells while calling for more extensive testing of melanoma samples as a prerequisite of further preclinical evaluation of FLU antineoplastic potential.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020090
- 003
- CZ-PrNML
- 005
- 20210830101708.0
- 007
- ta
- 008
- 210728s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.tiv.2020.104930 $2 doi
- 035 __
- $a (PubMed)32652169
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Rudolf, K $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic
- 245 13
- $a An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole / $c K. Rudolf, E. Rudolf
- 520 9_
- $a Mitotic catastrophe induced by mictotubule-targeting drugs such as benzimidazole carbamates has been demonstrated to be an efficient mechanism for suppression of tumor cells growth and proliferation, with variable resulting endpoints. The present study was designed to explore some of these endpoints; i.e. the apoptosis as well as autophagy and their related signaling in several stabilized cell lines as well as human explant melanoma cells treated with flubendazole (FLU). FLU-induced mitotic catastrophe resulted in mitochondrial and caspase-dependent apoptosis, which occurred at various rates in all treated cells during 96 h of treatment. The process was characterized by enhanced transcriptional activity of TP53 and NF-κB as well as upregulated Noxa expression. Also, inactivation of Bcl-2, BclXL and Mcl-1 proteins by JNK mediated phosphorylation was observed. Although increased autophagic activity took place in treated cells too, no discernible functional linkage with ongoing cell death process was evidenced. Together these results advance our evidence over the effectiveness of FLU cytotoxicity-related killing of melanoma cells while calling for more extensive testing of melanoma samples as a prerequisite of further preclinical evaluation of FLU antineoplastic potential.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a protinádorové látky $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a autofagie $x účinky léků $7 D001343
- 650 _2
- $a buněčný cyklus $x účinky léků $7 D002453
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a cytochromy c $x metabolismus $7 D045304
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a JNK mitogenem aktivované proteinkinasy $x metabolismus $7 D048031
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mebendazol $x analogy a deriváty $x farmakologie $7 D008463
- 650 _2
- $a melanom $x farmakoterapie $x metabolismus $7 D008545
- 650 _2
- $a membránový potenciál mitochondrií $x účinky léků $7 D053078
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mitóza $7 D008938
- 650 _2
- $a protein MCL-1 $x metabolismus $7 D064549
- 650 _2
- $a protoonkogenní proteiny c-bcl-2 $x metabolismus $7 D019253
- 650 _2
- $a nádorový supresorový protein p53 $x metabolismus $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rudolf, E $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic. Electronic address: rudolf@lfhk.cuni.cz
- 773 0_
- $w MED00004536 $t Toxicology in vitro : an international journal published in association with BIBRA $x 1879-3177 $g Roč. 68, č. - (2020), s. 104930
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32652169 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101708 $b ABA008
- 999 __
- $a ok $b bmc $g 1690807 $s 1140536
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 68 $c - $d 104930 $e 20200708 $i 1879-3177 $m Toxicology in vitro $n Toxicol In Vitro $x MED00004536
- LZP __
- $a Pubmed-20210728